LON:ABDX Abingdon Health (ABDX) Share Price, News & Analysis GBX 9.50 -0.25 (-2.56%) As of 07/16/2026 10:56 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock About Abingdon Health Stock (LON:ABDX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Abingdon Health alerts:Sign Up Key Stats Today's Range 9.50▼ 1050-Day Range 9.50▼ 1352-Week Range 5.10▼ 13Volume5,535 shsAverage Volume281,822 shsMarket Capitalization£23.85 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests. The Company offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. This ability has a significant role to play in improving life across the world. To support this aim Abingdon Health has also developed AppDx®, a customisable image capturing technology and algorithm that transforms a smartphone into a self-sufficient, standalone lateral-flow reader. Founded in 2008, Abingdon Health is headquartered in York, England. Read More Receive ABDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abingdon Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ABDX Stock News HeadlinesAbingdon Healt. Regulatory NewsMay 28, 2026 | lse.co.ukAbingdon Health (ABDX) Supports UK Rollout of Rapid Stroke Test LVOneMay 12, 2026 | uk.finance.yahoo.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. | Porter & Company (Ad)AIM Market Roundup: Abingdon Health, Autins, IQEMay 6, 2026 | uk.finance.yahoo.comAbingdon Health shares to begin trading on US OTCQB market from 21 AprilApril 14, 2026 | uk.finance.yahoo.comAbingdon Health chair on H1 performance, new contracts, OTC admission, and the path aheadApril 3, 2026 | finance.yahoo.comAbingdon Health up 14% after it wins £4.8m of US contracts for multiplex diagnostic test developmentMarch 30, 2026 | uk.finance.yahoo.comAbingdon Healt. Share Chat (ABDX)March 12, 2026 | lse.co.ukSee More Headlines ABDX Stock Analysis - Frequently Asked Questions How have ABDX shares performed this year? Abingdon Health's stock was trading at GBX 6.27 at the beginning of the year. Since then, ABDX stock has increased by 51.6% and is now trading at GBX 9.50. How were Abingdon Health's earnings last quarter? Abingdon Health Plc (LON:ABDX) released its quarterly earnings results on Tuesday, March, 17th. The company reported ($0.43) earnings per share (EPS) for the quarter. Abingdon Health had a negative net margin of 33.88% and a negative trailing twelve-month return on equity of 55.91%. How do I buy shares of Abingdon Health? Shares of ABDX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Abingdon Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Abingdon Health investors own include 4D pharma (DDDD), genedrive (GDR), Novacyt (NCYT), Rolls-Royce Holdings plc (RR.L), Tullow Oil (TLW), Active Energy Group (AEG) and B&M European Value Retail (BME). Company Calendar Last Earnings3/17/2026Today7/16/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolLON:ABDX CIKN/A Webwww.abingdonhealth.com Phone44 19 0440 6082FaxN/AEmployees84Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£796.37 thousand Net Margins-33.88% Pretax MarginN/A Return on Equity-55.91% Return on Assets-17.93% Debt Debt-to-Equity Ratio15.05 Current Ratio1.91 Quick Ratio1.96 Sales & Book Value Annual Sales£9.57 million Price / Sales2.49 Cash FlowGBX 4.22 per share Price / Cash Flow2.25 Book ValueGBX 0.73 per share Price / Book13.05Miscellaneous Outstanding Shares251,078,000Free FloatN/AMarket Cap£23.85 million OptionableNot Optionable Beta0.16 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (LON:ABDX) was last updated on 7/17/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abingdon Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abingdon Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABDX Stock Alerts